FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules
暂无分享,去创建一个
[1] J. Skolnick,et al. A threading-based method (FINDSITE) for ligand-binding site prediction and functional annotation , 2008, Proceedings of the National Academy of Sciences.
[2] J. Skolnick,et al. Comprehensive prediction of drug-protein interactions and side effects for the human proteome , 2015, Scientific Reports.
[3] Hongyi Zhou,et al. FINDSITEcomb: A Threading/Structure-Based, Proteomic-Scale Virtual Ligand Screening Approach , 2013, J. Chem. Inf. Model..
[4] Hongyi Zhou,et al. Fold recognition by combining sequence profiles derived from evolution and from depth‐dependent structural alignment of fragments , 2004, Proteins.
[5] Yang Zhang,et al. BSP‐SLIM: A blind low‐resolution ligand‐protein docking approach using predicted protein structures , 2012, Proteins.
[6] Jeffrey Skolnick,et al. Template‐based protein structure modeling using TASSERVMT , 2012, Proteins.
[7] Gonzalo López,et al. Assessment of ligand binding residue predictions in CASP8 , 2009, Proteins.
[8] J. Settleman,et al. Communication in Drug Development: “Translating” Scientific Discovery , 2016, Cell.
[9] Yang Zhang,et al. Scoring function for automated assessment of protein structure template quality , 2004, Proteins.
[10] Sara Reardon,et al. Project ranks billions of drug interactions , 2013, Nature.
[11] S. Henikoff,et al. Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] Guigang Zhang,et al. Deep Learning , 2016, Int. J. Semantic Comput..
[13] Jeffrey Skolnick,et al. Fr-TM-align: a new protein structural alignment method based on fragment alignments and the TM-score , 2008, BMC Bioinformatics.
[14] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[15] G J Williams,et al. The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1978, Archives of biochemistry and biophysics.
[16] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[17] E. Marchiori,et al. Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile , 2013, PloS one.
[18] Y.Z. Chen,et al. Ligand–protein inverse docking and its potential use in the computer search of protein targets of a small molecule , 2001, Proteins.
[19] Silvio C. E. Tosatto,et al. The Pfam protein families database in 2019 , 2018, Nucleic Acids Res..
[20] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[21] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[22] Zhenming Liu,et al. An Unbiased Method To Build Benchmarking Sets for Ligand-Based Virtual Screening and its Application To GPCRs , 2014, J. Chem. Inf. Model..
[23] Michal Brylinski,et al. FINDSITELHM: A Threading-Based Approach to Ligand Homology Modeling , 2009, PLoS Comput. Biol..
[24] R. W. Hansen,et al. The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.
[25] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[26] Yoshihiro Yamanishi,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.
[27] David Ryan Koes,et al. Protein-Ligand Scoring with Convolutional Neural Networks , 2016, Journal of chemical information and modeling.
[28] David Weininger,et al. SMILES. 2. Algorithm for generation of unique SMILES notation , 1989, J. Chem. Inf. Comput. Sci..
[29] Yang Zhang,et al. Recognizing protein-ligand binding sites by global structural alignment and local geometry refinement. , 2012, Structure.
[30] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[31] S. Collina,et al. Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases , 2017, ChemMedChem.
[32] Chang Liu,et al. Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization , 2013, J. Chem. Inf. Model..
[33] Jonathan Bard,et al. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. , 2004, Analytical biochemistry.
[34] E. Hanse,et al. Cytosolic malate dehydrogenase activity helps support glycolysis in actively proliferating cells and cancer , 2017, Oncogene.
[35] Michael M. Mysinger,et al. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.
[36] A Srinivas Reddy,et al. Virtual screening in drug discovery -- a computational perspective. , 2007, Current protein & peptide science.
[37] Jürgen Bajorath,et al. New methodologies for ligand-based virtual screening. , 2005, Current pharmaceutical design.
[38] Hongyi Zhou,et al. Experimental validation of FINDSITEcomb virtual ligand screening results for eight proteins yields novel nanomolar and micromolar binders , 2014, Journal of Cheminformatics.
[39] M. Fischbach,et al. Repurposing libraries of eukaryotic protein kinase inhibitors for antibiotic discovery , 2009, Proceedings of the National Academy of Sciences.
[40] Michal Brylinski,et al. Comprehensive Structural and Functional Characterization of the Human Kinome by Protein Structure Modeling and Ligand Virtual Screening , 2010, J. Chem. Inf. Model..
[41] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[42] Yoshihiro Yamanishi,et al. Drug Side-Effect Prediction Based on the Integration of Chemical and Biological Spaces , 2012, J. Chem. Inf. Model..
[43] Michal Brylinski,et al. Q‐DockLHM: Low‐resolution refinement for ligand comparative modeling , 2009, J. Comput. Chem..
[44] Ruben Abagyan,et al. ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..
[45] N. Nikolova,et al. International Union of Pure and Applied Chemistry, LUMO energy ± The Lowest Unoccupied Molecular Orbital (LUMO) , 2022 .
[46] Jeffrey Skolnick,et al. FINDSITE(X): a structure-based, small molecule virtual screening approach with application to all identified human GPCRs. , 2012, Molecular pharmaceutics.
[47] Michal Brylinski,et al. Q‐Dock: Low‐resolution flexible ligand docking with pocket‐specific threading restraints , 2008, J. Comput. Chem..
[48] Todd J. A. Ewing,et al. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..
[49] G. Phillips,et al. Structure and Substrate Specificity of a Eukaryotic Fucosidase from Fusarium graminearum* , 2014, The Journal of Biological Chemistry.
[50] Chuang Liu,et al. Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..
[51] Izhar Wallach,et al. AtomNet: A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug Discovery , 2015, ArXiv.
[52] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[53] J. E. Blanchard,et al. A small molecule discrimination map of the antibiotic resistance kinome. , 2011, Chemistry & biology.
[54] D. Bojanic,et al. Impact of high-throughput screening in biomedical research , 2011, Nature Reviews Drug Discovery.
[55] Robert C. Glen,et al. Similarity Metrics and Descriptor Spaces – Which Combinations to Choose? , 2006 .